Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cisplatin, Gemcitabine Hydrochloride, and Sorafenib Tosylate in Treating Patients With Transitional Cell Cancer of the Bladder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01222676
Recruitment Status : Unknown
Verified October 2010 by National Cancer Institute (NCI).
Recruitment status was:  Recruiting
First Posted : October 18, 2010
Last Update Posted : August 12, 2013
Sponsor:
Information provided by:
National Cancer Institute (NCI)